Are you Dr. Bark?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 7 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
117 Constitution Dr
Orangeburg, NY 10962Phone+1 845-359-7553Fax+1 845-359-7553- Is this information wrong?
Summary
- Dr. Nigel Bark, MD is a board certified psychiatrist in Orangeburg, New York. He is currently licensed to practice medicine in New York and New Jersey. He is an Associate Professor at Albert Einstein College of Medicine.
Education & Training
- University of Cambridge School of MedicineClass of 1966
Certifications & Licensure
- NJ State Medical License Current
- NY State Medical License 1976 - 2024
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics Start of enrollment: 2005 May 01
- An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia Start of enrollment: 2005 Nov 01
- Study of Vitamin D in the Severely Mentally Ill Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- Among the severely mentally ill, who responds to ziprasidone?Nigel Bark, Nicholas Lawson, Eileen Trigoboff, Rodica Varadi, Jeffery Grace, Josie Olympia, Nighat Sindhu, Tom Watson, Mohamed El-Defrawi, Punyabrata Roy> ;Clinical Schizophrenia & Related Psychoses. 2016 Jan 18
- 10 citationsPrisoner mental health in the USA.Nigel Bark> ;International Psychiatry. 2014 Aug 1
- 33 citationsEffects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: A randomiz...Robert C. Smith, Hua Jin, Chunbo Li, Nigel Bark, Anantha Shekhar, Sauburah Dwivedi, Catherine Mortiere, James B. Lohr, Qiaoyan Hu, John M. Davis> ;Schizophrenia Research. 2013 Jan 1
- Join now to see all
Authored Content
- Hydroxychloroquine - Does It Have Clinical Value in COVID-19? A Point, Counterpoint DiscussionNovember 2020